Jessica Zbinden-Webster was diagnosed with a rare kind of basal cell carcinoma when she was just 26, now she campaigns to ...

Pennington: Zydus Lifesciences' venture capital arm, Zynext Ventures USA LLC, has announced its investment in Feldan ...

Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...

Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...

As the celebrity chef says the disease put him through a lot of despair, the NHS has advised on how people can reduce their ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

For example, a 5/1 ARM will have the same rate for the first five years, then can adjust each year after that—meaning the rate might go up or down, based on the market. An ARM isn’t for everyone.

In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against other best UK stocks to invest in. Like most of the world, the United Kingdom is also facing ...

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...